Vanda Pharmaceuticals Inc. (VNDA) NASDAQ

4.95

+0.035(+0.71%)

Updated at September 30 01:30PM

Currency In USD

Valuation

Market Cap278.53M
Enterprise Value188.58M
P/E Ratio-4.33
PEG Ratio0.08
Price/Sales Ratio1.43
Price/Book Ratio0.6
Enterprise/Revenue1.09
Enterprise/EBITDA-2.71

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.33
Operating Margin-0.51

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.13

Income Statement

Revenue198.77M
Revenue/Share3.45
Gross Profit187.46M
EBITDA-32.53M
Net Income-18.9M
Diluted EPS-0.33

Balance Sheet

Total Cash325.55M
Total Cash/Share5.52
Total Debt11.64M
Total Debt/Equity0.02
Current Ratio3.25
Book Value Per Share8.24

Price History

52-Week Change4.69
52-Week High5.55
52-Week Low3.81
Moving Average 50 Days4.56
Moving Average 200 Days4.56

Statistics

Average Volume472,763
Shares Outstanding59.09M
% Held by Institutions76.29

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A